COMPASS Pathways plc (FRA:5Y6)
Germany · Delayed Price · Currency is EUR 10.00
-0.20 (-1.96%)
Last updated: Oct 23, 2026, 3:25 PM CEST
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of €1.38 billion as of October 23, 2026. Its market cap has increased by 163.92% in one year.
Market Cap
1.38B
Enterprise Value
1.04B
Revenue
n/a
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 2020, COMPASS Pathways's market cap has increased from 449.43M to 1.38B, an increase of 207.61%. That is a compound annual growth rate of 20.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 1.38B | 145.01% |
| Dec 31, 2025 | 564.27M | 125.88% |
| Dec 31, 2024 | 249.81M | -49.02% |
| Dec 29, 2023 | 489.98M | 53.16% |
| Dec 30, 2022 | 319.91M | -60.55% |
| Dec 31, 2021 | 810.94M | -42.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.30B |
| Siemens Healthineers AG | 46.59B |
| Bayer Aktiengesellschaft | 43.21B |
| Fresenius SE & Co. KGaA | 25.97B |
| Carl Zeiss Meditec AG | 3.11B |
| Dermapharm Holding SE | 1.90B |
| Drägerwerk AG & Co. KGaA | 1.61B |
| Redcare Pharmacy NV | 1.60B |